View Older Stories View More Recent Stories

Feb 16, 2021 04:48PM Form SC 13G GERON CORP Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Dyne Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Adverum Biotechnologies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Inhibrx, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G Helix Acquisition Corp Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:48PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G FIVE PRIME THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G BCTG Acquisition Corp. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G/A Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G Milestone Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:47PM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:46PM Form SC 13G Verona Pharma plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:43PM Form SC 13G/A Prevail Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 16, 2021 04:40PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 11, 2021 04:47PM Form SC 13G/A Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 11, 2021 08:15AM Cyteir Therapeutics Secures $80 Million in Series C Financing to Advance Clinical Trials of Lead RAD51 Program
Feb 10, 2021 04:50PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:49PM Form SC 13G/A Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:48PM Form SC 13G/A ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:47PM Form SC 13G/A Cardiff Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:35PM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 04:32PM Form SC 13G Keros Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 10, 2021 06:30AM Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children
Feb 8, 2021 05:17PM Form SC 13G/A Iterum Therapeutics plc Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 8, 2021 07:00AM Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
Feb 5, 2021 07:05AM Orchard Therapeutics Plc (ORTX) Reports $150M Strategic PIPE Financing from 24.12M Share Sale at $6.22/Sh
Feb 5, 2021 07:00AM Orchard Therapeutics Announces $150 Million Strategic Financing
Feb 5, 2021 07:00AM Orchard Therapeutics Announces $150 Million Strategic Financing
Feb 4, 2021 09:47PM Form 3 Vor Biopharma Inc. For: Feb 04 Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 4, 2021 08:00AM PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer
Jan 29, 2021 04:31PM Form SC 13G CytomX Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Jan 29, 2021 08:00AM Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Jan 27, 2021 08:30AM Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders
Jan 25, 2021 07:00AM TScan Therapeutics Announces $100 Million Series C Financing
Jan 19, 2021 06:30AM Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
Jan 13, 2021 02:00AM IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology
Jan 8, 2021 01:59PM CiVi Biopharma to Participate in HC Wainwright BioConnect 2021 Conference
Jan 8, 2021 08:00AM DiCE Molecules Announces $80 Million Series C Financing
Jan 7, 2021 07:00AM Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Jan 7, 2021 07:00AM Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
Jan 7, 2021 07:00AM Abcuro Raises $42 Million in Series A-1 Financing, Appoints John B. Edwards as Executive Chair of the Board of Directors and David de Graaf, Ph.D. as Chief Executive Officer
Jan 5, 2021 08:00AM Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte
Dec 17, 2020 04:41PM Form SC 13G MIRAGEN THERAPEUTICS, Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 16, 2020 05:25PM Form SC 13D/A Solid Biosciences Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 16, 2020 10:00AM Ivantis Recognized For Innovation, Excellence And Company Culture
Dec 16, 2020 06:00AM Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
Dec 14, 2020 08:30AM Locanabio Announces $100 Million Series B Financing to Advance Portfolio of Novel RNA-Targeted Gene Therapies for Neurodegenerative, Neuromuscular and Retinal Diseases
Dec 11, 2020 07:32AM Solid Biosciences (SLDB) Announces $90 Million Private Placement of Common Stock
Dec 11, 2020 07:30AM Solid Biosciences Announces $90 Million Private Placement
Dec 9, 2020 09:00AM Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio Breast Cancer Symposium 2020 Virtual Meeting
View More Recent Stories View Older Stories